TY  - GEN
AU  - Kashyap,Trinayan
AU  - Argueta,Christian
AU  - Aboukameel,Amro
AU  - Unger,Thaddeus John
AU  - Klebanov,Boris
AU  - Mohammad,Ramzi M
AU  - Muqbil,Irfana
AU  - Azmi,Asfar S
AU  - Drolen,Claire
AU  - Senapedis,William
AU  - Lee,Margaret
AU  - Kauffman,Michael
AU  - Shacham,Sharon
AU  - Landesman,Yosef
TI  - Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death
SN  - 1949-2553
PY  - 2018///0223
KW  - Active Transport, Cell Nucleus
KW  - drug effects
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Bone Neoplasms
KW  - drug therapy
KW  - Bortezomib
KW  - Cell Death
KW  - Cell Line, Tumor
KW  - Cell Nucleus
KW  - Dose-Response Relationship, Drug
KW  - Drug Resistance, Neoplasm
KW  - Drug Synergism
KW  - Female
KW  - Fibrosarcoma
KW  - Humans
KW  - Hydrazines
KW  - Karyopherins
KW  - antagonists & inhibitors
KW  - Mice, Inbred ICR
KW  - Mice, SCID
KW  - NF-KappaB Inhibitor alpha
KW  - genetics
KW  - NF-kappa B
KW  - Osteosarcoma
KW  - Phosphorylation
KW  - Proteasome Endopeptidase Complex
KW  - metabolism
KW  - Proteasome Inhibitors
KW  - Proteolysis
KW  - RNA Interference
KW  - Receptors, Cytoplasmic and Nuclear
KW  - Signal Transduction
KW  - Time Factors
KW  - Transcription Factor RelA
KW  - Transfection
KW  - Triazoles
KW  - Exportin 1 Protein
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.18632/oncotarget.12428
ER  -